Post-thrombotic syndrome stenting is an endovascular approach used to address the chronic venous obstruction that can develop after a deep vein thrombosis (DVT) fails to fully resolve. Post-thrombotic syndrome, often abbreviated PTS, is a condition in which residual scarring and narrowing within a vein following a prior clot leads to long-term symptoms such as leg swelling, pain, skin changes, and, in more advanced cases, venous ulcers. This article reviews what PTS is, how stenting is used to address the underlying outflow obstruction, and what patients can expect from this category of treatment.
What Causes Post-Thrombotic Syndrome?
Post-thrombotic syndrome develops when a deep vein thrombosis leaves behind scar tissue, chronic narrowing, or persistent occlusion within the affected vein, most often in the iliofemoral segment of the leg. Even after the original clot has been treated, the vein wall and valves can remain damaged, and blood flow returning to the heart may continue to face resistance through the scarred or narrowed segment. Over time, this sustained outflow obstruction contributes to elevated venous pressure in the leg, which is the mechanism generally understood to drive the swelling, discomfort, and skin changes associated with PTS.
How Does Recanalization Stenting Address Chronic Venous Occlusion?
Recanalization stenting is the general term for the endovascular technique used to reopen and support a chronically occluded or narrowed vein. The procedure typically involves crossing the obstructed segment with a wire and catheter, using balloon angioplasty to open the narrowed pathway, and then deploying a self-expanding stent to hold the vessel open and maintain a channel for blood flow. This approach is aimed at relieving the outflow obstruction that underlies many PTS symptoms, rather than treating the skin or soft tissue changes directly. Appropriate candidacy for recanalization stenting is determined by the treating physician after reviewing imaging that maps the extent and character of the chronic occlusion.
What Role Does the Atlas Venous Stent Play in PTS Treatment?
Among the device platforms used in this space, the Atlas Venous Stent is a self-expanding nitinol implant system indicated, per the manufacturer, for iliofemoral venous outflow obstruction and post-thrombotic syndrome, along with venous stenoses caused by extrinsic compression or scar tissue. It is designed to maintain patency and support flow through the treated segment as part of a broader strategy to relieve chronic venous insufficiency symptoms. As with any venous stent platform, suitability for a specific patient, sizing, and placement are determined by the treating physician in line with the device's Instructions for Use (IFU), and contraindications such as severe vessel tortuosity, diameter mismatch, or active local infection are considered during patient selection.
What Can Patients Expect in Terms of Symptom Change?
Because PTS symptoms result from a combination of outflow obstruction and valve damage, restoring flow through recanalization stenting is generally understood to reduce venous pressure and, in appropriate candidates, contribute to improvement in swelling and discomfort. However, stenting does not reverse valve damage that may have already occurred, so outcomes vary based on individual disease severity and duration. Ongoing use of compression therapy and other conservative measures is often continued alongside stenting as part of a comprehensive PTS management plan determined by the treating physician.
When Should Someone with PTS Symptoms Seek Evaluation?
Patients experiencing persistent leg swelling, aching, skin discoloration, or the development of a venous ulcer after a prior DVT are generally encouraged to seek evaluation from a vascular specialist to determine whether chronic venous occlusion is contributing to their symptoms. Sudden worsening of leg swelling, new severe pain, or signs of skin infection around an ulcer should prompt patients to seek immediate medical care.
General information about the broader device category used in these procedures is available on the venous stents product page.
Does stenting cure post-thrombotic syndrome?
Stenting is used to restore venous outflow in appropriate candidates and is not described as a cure. Because PTS often involves valve damage in addition to obstruction, individual outcomes vary, and the treating physician determines expected benefit based on each patient's condition.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.